Full-Time
Join us to build the future of drug discovery
Confirmed live in the last 24 hours
Vevo Therapeutics
11-50 employees
AI-driven in vivo drug discovery platform
Junior
San Bruno, CA, USA
Hybrid position requiring in-office presence.
- Single-cell bioinformatics on large atlas datasets
- Machine learning applied to genomics data and cheminformatics
- High throughput synthetic lethal oncology genomics screens and subsequent target validation of individual genes
- Junior Scientists with tissue culture, single-cell sample preparation, laboratory automation using robotics, and biochemical assays for target validation and mechanistic investigation
- Medicinal chemistry, particularly in small molecule oncology
Vevo Therapeutics specializes in drug discovery by using advanced AI models and its Mosaic platform to generate high-resolution in vivo data, which studies drug interactions within living organisms. This method allows them to identify new drug targets and candidates that traditional approaches may miss. They serve pharmaceutical companies and research institutions by providing insights into drug efficacy and gene expression at a single-cell level, making the drug discovery process faster and more cost-effective. The goal of Vevo Therapeutics is to enhance drug development, leading to better treatments for a broader range of patients.
Company Stage
Seed
Total Funding
$11.7M
Headquarters
San Francisco, California
Founded
2022
6 month growth
↑ 0%1 year growth
↑ 4%2 year growth
↑ 13%
Simplify's Take
What believers are saying
- Rising demand for single-cell RNA sequencing boosts Mosaic platform's relevance.
- AI-driven drug discovery is gaining traction in pharmaceutical industry.
- Partnerships with academic institutions provide access to cutting-edge research.
What critics are saying
- Intense competition from other AI-driven drug discovery platforms.
- Rapid technological advancements may render current platform obsolete.
- Data privacy concerns could lead to regulatory scrutiny.
What makes Vevo Therapeutics unique
- Vevo uses Mosaic platform for high-resolution in vivo drug discovery.
- AI models enhance Vevo's drug discovery by analyzing diverse patient data.
- Single-cell RNA profiling offers insights into drug efficacy across patient populations.
Help us improve and share your feedback! Did you find this helpful?